Table 3.
Secondary outcome data: fatigue score (CFQ).
| I-CBT 8 | CBT 16 | WLC | |
|---|---|---|---|
| Fatigue score | |||
| Baseline | 25.2 (23.9–26.4) | 25.3 (24.2–26.5) | 25.8 (24.7–27.0) |
| Post-intervention* | 20.7 (19.1–22.4) | 18.7 (17.1–20.4) | 24.1 (22.6–25.7) |
| Follow-up 1 year | 19.3 (17.4–21.2) | 19.7 (17.4–21.9) | |
| Mean difference, additional effect relative to baseline at post-intervention | 4.8 (−0.4 to 9.9) p = 0.07 | 5.9 (0.5–10.5) p = 0.03 | |
Data are mean scores and mean difference, additional effect relative to baseline post intervention with a 95% CI. Chalder Fatigue Questionnaire (0–33), lower score, fewer symptoms, better function.
*
Post-intervention: (I-CBT 8: 21 weeks from baseline. CBT 16: 20 weeks from baseline. WLC 18 weeks from baseline). Follow-up: (52 weeks from baseline).